Apple Reiterated at Outperform and 4 Reiterated Ratings Not to Miss

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on December 21st.

TIBCO Software (NASDAQ:TIBX): UBS reiterated its rating of Buy for this company and changed its price target from $32 to $30.

MasterCard (NYSE:MA): Argus reiterated its rating of Buy for this company and changed its price target from $525 to $575.

Our 20-page proprietary analysis of Apple’s stock is ready. Click here to get your Cheat Sheet report now.

Insulet (NASDAQ:PODD): Canaccord Genuity reiterated its rating of Buy for this company and changed its price target from $24.5 to $29.

Apple (NASDAQ:AAPL): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $750 to $725.

Endocyte (NASDAQ:ECYT): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $12 to $15.

Don’t Miss: Apple Won’t Back Down.